Bicara Therapeutics, Inc. (BCAX)
22.02
-0.62
(-2.74%)
USD |
NASDAQ |
Sep 21, 16:00
22.02
0.00 (0.00%)
After-Hours: 20:00
Bicara Therapeutics Market Cap : 1.452B for Sept. 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 18, 2026 | 1.493B |
| September 17, 2026 | 1.489B |
| September 16, 2026 | 1.450B |
| September 15, 2026 | 1.495B |
| September 14, 2026 | 1.530B |
| September 11, 2026 | 1.504B |
| September 10, 2026 | 1.523B |
| September 09, 2026 | 1.559B |
| September 08, 2026 | 1.563B |
| September 04, 2026 | 1.528B |
| September 03, 2026 | 1.539B |
| September 02, 2026 | 1.553B |
| September 01, 2026 | 1.544B |
| August 31, 2026 | 1.524B |
| August 28, 2026 | 1.545B |
| August 27, 2026 | 1.637B |
| August 26, 2026 | 1.630B |
| August 25, 2026 | 1.621B |
| August 24, 2026 | 1.555B |
| August 21, 2026 | 1.576B |
| August 20, 2026 | 1.608B |
| August 19, 2026 | 1.705B |
| August 18, 2026 | 1.643B |
| August 17, 2026 | 1.644B |
| August 14, 2026 | 1.601B |
| Date | Value |
|---|---|
| August 13, 2026 | 1.558B |
| August 12, 2026 | 1.624B |
| August 11, 2026 | 1.567B |
| August 10, 2026 | 1.828B |
| August 07, 2026 | 1.850B |
| August 06, 2026 | 1.814B |
| August 05, 2026 | 1.697B |
| August 04, 2026 | 1.711B |
| August 03, 2026 | 1.687B |
| July 31, 2026 | 1.776B |
| July 30, 2026 | 1.722B |
| July 29, 2026 | 1.697B |
| July 28, 2026 | 1.762B |
| July 27, 2026 | 1.823B |
| July 24, 2026 | 1.771B |
| July 23, 2026 | 1.818B |
| July 22, 2026 | 1.833B |
| July 21, 2026 | 1.845B |
| July 20, 2026 | 1.780B |
| July 17, 2026 | 1.820B |
| July 16, 2026 | 1.809B |
| July 15, 2026 | 1.843B |
| July 14, 2026 | 1.842B |
| July 13, 2026 | 1.845B |
| July 10, 2026 | 1.895B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 9.710B |
| Oncolytics Biotech, Inc. | 95.71M |
| Sangamo Therapeutics, Inc. | 60.03M |
| Sarepta Therapeutics, Inc. | 2.126B |
| Anixa Biosciences, Inc. | 93.38M |
Market Cap Related Metrics
| PEG Ratio | -0.1120 |
| Price to Book Value | 3.097 |
| Price | 22.02 |
| Earnings Yield | -14.01% |
| PEGY Ratio | -0.1120 |